AChR autoimmunity
Typical setting: The commonest antibody-defined generalised subtype.
IgG targets postsynaptic receptors and recruits complement, reducing receptor density and damaging junctional folds.
MG module
Understand myasthenia gravis as antibody-mediated failure of postsynaptic neuromuscular transmission causing fatigable ocular, bulbar, limb and respiratory weakness.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Autoimmune subtype, thymic disease and physiological stress shape presentation and deterioration.
Typical setting: The commonest antibody-defined generalised subtype.
IgG targets postsynaptic receptors and recruits complement, reducing receptor density and damaging junctional folds.
Typical setting: Seronegative AChR testing with compatible disease, often prominent bulbar weakness.
Antibodies disrupt the signalling scaffold that clusters and maintains functional receptors.
Typical setting: Anterior mediastinal tumour associated with MG.
Abnormal thymic selection permits autoreactive T cells; all confirmed MG requires appropriate thymic assessment.
Typical setting: Sudden worsening during infection, surgery, pregnancy or postpartum change.
Inflammation, fever, altered medication delivery and increased respiratory demand expose limited neuromuscular reserve.
Typical setting: Selected antibiotics, magnesium, beta-blockers, anaesthetic agents and other drugs.
Presynaptic release, postsynaptic responsiveness or respiratory reserve may be impaired; risk is drug- and patient-specific and requires clinical review rather than blanket withdrawal.
Mechanism chain
Antibodies reduce postsynaptic reserve until repeated impulses fail to trigger contraction.
Autoreactive T and B cells generate antibodies against AChR, MuSK, LRP4 or related targets.
Receptor blockade/internalisation, complement injury or failed receptor clustering reduces effective acetylcholine signalling.
Keep exploring